BioInformant Worldwide, L.L.C. Research

BioInformant Worldwide, LLC, is a U.S. based research firm that specializes in market intelligence for the stem cell industry. We are the only company that has specifically served the stem cell sector since it emerged, and our singular focus allows our team allows us to produce data that enables you to better understand your markets, competitors, and customers.

To date, BioInformant has been featured on prominent news outlets that include Nature Biotechnology, the Wall Street Journal, CBS News, Yahoo Finance, Medical Ethics, MarketWatch, the Center for BioNetworking, and many more.

In addition, our management team comes from a BioInformatics background – the science of collecting and analyzing complex genetic codes – and we are trained in applying these advanced data analysis techniques to the field of market research.

As a stem cell research firm, we use technology to track and identify profitable opportunities within the stem cell sector and provide this data to clients pursuing aggressive growth. Serving Fortune 500 leaders that include GE Healthcare, Pfizer, Goldman Sachs, Beckton Dickinson, Thermo Fisher Scientific, and many more, BioInformant is your trusted source of stem cell industry data.
BioInformant Worldwide, L.L.C. Research

List of reports from BioInformant Worldwide, L.L.C. Research

The Market for Stem Cell Biobanking and Storage - Size, Segments, and Trends.
6/1/2015 | published by: BioInformant Worldwide, L.L.C.
... the stem cell biobanking market. This global strategic report is produced for: Executives of Industrial-Scale Biobanks Management of Stem Cell Product Companies Management of Stem Cell Therapy Companies Biobanking Industry Investors It is designed to ...  |  read more...
USD 1,395
Complete 2015-16 Induced Pluripotent Stem Cell (iPSC) Industry Report
4/1/2015 | published by: BioInformant Worldwide, L.L.C.
... affecting industry patent rights, announcement of an iPSC cellular therapy clinic scheduled to open in 2019, and much more. Furthermore, iPSC patent dominance continues to cluster in specific geographic regions, while clinical trial and scientific ...  |  read more...
USD 3,795
Complete 2015-16 Global Cord Blood Banking Industry Report.
11/1/2014 | published by: BioInformant Worldwide, L.L.C.
... increased the cost structure of cord blood banks A decline in cord blood transplants in 2013, within the U.S. and other geographical regions Low rates of turnover for stored cord blood units Expensive cord blood ...  |  read more...
USD 3,795
Stem Cell Research Products - Opportunities, Tools, and Technologies
5/1/2014 | published by: BioInformant Worldwide, L.L.C.
... discovery, as the first mouse embryonic stem cells were derived from embryos in 1981, but it was not until 1995 that the first successful culturing of embryonic stem cells from non-human primates occurred and not ...  |  read more...
USD 3,495
7 Things You Need to Know to Profit from Feeder-Free Culture
1/1/2014 | published by: BioInformant Worldwide, L.L.C.
... the topic of feeder-dependent versus feeder-free culture, we completed an end-user survey on this topic. The key findings are synthesized for you in this report, titled "7 Things You Need to Know to Profit from ...  |  read more...
USD 229
Capitalizing on Opportunities in Cord Blood Industry Growth (2013 Version)
11/1/2013 | published by: BioInformant Worldwide, L.L.C.
... as of 2005, and now there are 485 worldwide. Cord blood banks now exist within 98 different countries around the world. That is a 21-fold increase (2,100%) in the companies involved in the industry, in ...  |  read more...
USD 3,995
Opportunities in Human Embryonic Stem Cell (hESC) Products - Trends and Forecasts to 2017
10/1/2013 | published by: BioInformant Worldwide, L.L.C.
... to differentiate into any mature cell type. Categorized by stage of life, several broad categories of stem cells exist, including: Embryonic stem cells, derived from blastocysts Post-natal stem cells, derived from newborn tissues Adult stem ...  |  read more...
USD 3,495
Complete 2013-14 U.S. Cord Blood Banking Industry Report
9/1/2013 | published by: BioInformant Worldwide, L.L.C.
... now exist in nearly every developed country, as well as within several developing nations. That is a 21-fold increase (2,100%) in the companies involved in the industry in less than a ten-year period. Within the ...  |  read more...
USD 3,995
Mesenchymal Stem Cells - Advances and Applications
6/1/2013 | published by: BioInformant Worldwide, L.L.C.
... intense therapeutic interest because they represent a population of cells with the potential to treat a wide range of acute and degenerative diseases. MSCs are advantageous over other stem cells types for a variety of ...  |  read more...
USD 3,495
Cord Blood Database
2/23/2012 | published by: BioInformant Worldwide, L.L.C.
... you want to sell to cord blood banks? Do you recognize the huge population of potential clients this market represents? If so, this may be a critical resource for your business. To allow you to ...  |  read more...
USD 995
Strategic Development of Neural Stem & Progenitor Cell Products
1/1/2012 | published by: BioInformant Worldwide, L.L.C.
... multipotent cells that differentiate into the main phenotypes of the nervous system. These cell types include neurons, astrocytes, and oligodendrocytes. Neural progenitor cells (NPCs) are the progeny of stem cell division that normally undergo a ...  |  read more...
USD 3,495
US: 800.298.5699
Int'l: +1.240.747.3093
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!